Form D · Biotechnology

Weo, LLC

Miami, FL · CIK 0001835648

Offering snapshot reported Aug 24, 2022 · SEC filing

Reported sold: $10.3M
Investors reported: 18
Minimum accepted: $500K
First sale: Dec 8, 2020

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$6,664,000 → $10,344,008
Reported investors15 → 18
Minimum accepted$25,000 → $500,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 24, 2022	Amendment	$10,344,008	$3,680,008vs Nov 30, 2021	18	SEC filing
Nov 30, 2021	Amendment	$6,664,000	$5,914,000vs Dec 9, 2020	15	SEC filing
Dec 9, 2020	Initial	$750,000	No comparison	2	SEC filing

Offering details

Securities: Equity
Exemptions: 06c
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-382672

We are in the second round of fundraising. First Round was for 8M and second round is now for 12M.

Source: Form D, filed Aug 24, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Stephanie Avitan	Director
Gilles Bazan	Director
Anthony Ginter	Executive, Promoter
Gerard Lopez	Director
Francois Marmion	Director
Laurent Pupunat	Director
Jeremy Vincent	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

1951 Nw 7 Th Avenue Cic Suite 600
Miami, FL, 33136